Fulcrum Therapeutics, Inc. (FULC)
3.70
-0.01
(-0.27%)
USD |
NASDAQ |
Oct 06, 09:44
Fulcrum Therapeutics EPS Diluted (Quarterly) : -0.3433 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3433 |
| March 31, 2026 | -0.2479 |
| December 31, 2025 | -0.3091 |
| September 30, 2025 | -0.313 |
| June 30, 2025 | -0.2765 |
| March 31, 2025 | -0.2826 |
| December 31, 2024 | -0.3071 |
| September 30, 2024 | -0.3476 |
| June 30, 2024 | 0.8714 |
| March 31, 2024 | -0.4335 |
| December 31, 2023 | -0.4001 |
| September 30, 2023 | -0.3885 |
| June 30, 2023 | -0.3849 |
| March 31, 2023 | -0.4149 |
| December 31, 2022 | -0.5018 |
| September 30, 2022 | -0.5137 |
| June 30, 2022 | -0.8332 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.6379 |
| December 31, 2021 | -0.5787 |
| September 30, 2021 | -0.5659 |
| June 30, 2021 | -0.602 |
| March 31, 2021 | -0.5395 |
| December 31, 2020 | -0.6435 |
| September 30, 2020 | -0.6956 |
| June 30, 2020 | -0.6575 |
| March 31, 2020 | -0.8122 |
| December 31, 2019 | -0.7131 |
| September 30, 2019 | -0.9749 |
| June 30, 2019 | -0.7052 |
| March 31, 2019 | -1.709 |
| December 31, 2018 | -0.4597 |
| September 30, 2018 | -0.4788 |
| June 30, 2018 | -0.3811 |
| March 31, 2018 | -0.3328 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -0.2295 |
| CNBX Pharmaceuticals, Inc. | -0.0001 |
| Arvinas, Inc. | 2.578 |
| Definium Therapeutics, Inc. | -1.436 |
| LeonaBio, Inc. | -0.8011 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.18M |
| Total Expenses (Quarterly) | 26.18M |
| Enterprise Value | -30.54M |
| Earnings Yield | -32.79% |
| Normalized Earnings Yield | -30.46 |